References
- Spiro RH: Salivary neoplasms, overview of a 35 year experience with 2,807 patients. Head Neck Surg 1986;8:177-184 https://doi.org/10.1002/hed.2890080309
- Fordice J, Kershaw C, El-Naggar A, Goepfert H: Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg 1999;125(2):149-152 https://doi.org/10.1001/archotol.125.2.149
- Teo PML, Chan ATC, Lee WY, Leung SF, Chan ESY, Mok CO: Failure patterns and factors affecting prognosis of salivary gland carcinoma: retrospective study. HKMJ 2000;6(1):29-36
- Park YW: Cellular and molecular characterization of adenoid cystic carcinoma of the salivary glands. J Kor Maxillofac Plast Reconst Surg 2005;27(2):110-122
- Park YW, Kim JH: Immunohistochemical assays for the expression of epidermal growth factor-signaling proteins in adenoid cystic carcinomas of human salivary glands. J Kor Maxillofac Plast Reconst Surg 2006;28(6):499-510
- Kim HS, Kim SM, Park YW: Immunohistochemical study on expression patterns of tumor growth related factors in salivary glands tumors. J Kor Maxillofac Plast Reconst Surg 2007;29(5):405-416
- O-charoenrat P, Rhys-Evans P, Modjtahedi H, Court W, Box G, Eccles S: Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion. Int J Cancer 2000;86:307-317 https://doi.org/10.1002/(SICI)1097-0215(20000501)86:3<307::AID-IJC2>3.0.CO;2-I
- El-Rayes BF, LoRusso PM: Targeting the epidermal growth factor receptor. Br J Cancer 2004;91:418-424 https://doi.org/10.1038/sj.bjc.6601921
- Khazaie K, Schirrmacher V, Lichtner RB: EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev 1993;12:255-274 https://doi.org/10.1007/BF00665957
- Kuan CT, Wikstrand CJ, Bigner DD: EGF mutant receptor VIII as a molecular target in cancer therapy. Endocr Relat Cancer 2001;8:83-96 https://doi.org/10.1677/erc.0.0080083
- Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C et al: EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHBEGF. Nature 1999;402:884-888 https://doi.org/10.1038/47260
- Alroy I, Alroy I, Yarden Y: The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions. FEBS Lett 1997;410:83-86 https://doi.org/10.1016/S0014-5793(97)00412-2
- Chan TO, Rittenhouse SE, Tsichlis PN: AKT/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 1999;68:965-1014 https://doi.org/10.1146/annurev.biochem.68.1.965
- Yarden Y, Sliwkowski M: Untangling the ErbB signaling network. Nat Rev Mol Cell Biol 2001;2:127-137 https://doi.org/10.1038/35052073
- Lewis TS, Shapiro PS, Ahn NG: Signal transduction through MAP kinase cascades. Adv Cancer Res 1997;74:49-139
- Vivanco I, Sawyers CL: The phosphatidylinositol 3-Kinase-Akt pathway in human cancer. Nat Rev Cancer 2002;2:489-501 https://doi.org/10.1038/nrc839
- Myoken Y, Myoken Y, Okamoto T, Sato JD, Kan M, McKEEHAN WL: Immunohistochemical study of overexpression of fibroblast growth Factor-1(FGT-1), FGT-2, and FGT Receptor-1 in human malignant salivary gland tumours. J Pathol 1996;178:429-436 https://doi.org/10.1002/(SICI)1096-9896(199604)178:4<429::AID-PATH495>3.0.CO;2-1
- Ishibashi H, Shiratuchi T, Nakagawa K, Onimaru M, Sugiura T, Sueishi K et al: Hypoxia-induced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release. Oral Oncol 2001;37(1):77-83 https://doi.org/10.1016/S1368-8375(00)00062-2
- Nagel H, Laskawi R, Wahlers A, Hemmerlein B: Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland. Histopathol 2004;44:222-231 https://doi.org/10.1111/j.0309-0167.2004.01814.x
- Park YW, In YS: Immunohistochemical assays for the expression of angiogenic signaling molecules and microvessel density in adenoid cystic carcinomas of human salivary glands. J Kor Oral Maxillofac Surg 2006;32(6):530-543
- In YS, Kim SM, Park YW: Comparative immunohistochemical assays for the expression of angiogenic factors in tumors of human salivary glands. J Kor Maxillofac Plast Reconst Surg 2007;29(1):10-23
- Jang JH, Kwon KJ, Park YW: Expressions of vascular metastasis related factors in murine orthotopic tumor models of salivary glands. J Kor Maxillofac Plast Reconst Surg 2007;29(6):499-508
- Yu F, Jiang XZ, Chen WT, Zhao YF, Zhou XJ: Microvessel density and expression of vascular endothelial growth factor in adenoid cystic carcinoma of salivary gland. Shanghai Kou Qiang Yi Xue 2003;12(6):443-446
- Perrot E, Davy N, Poubeau P, Arvin-Berod C: Chemotherapy with paclitaxel for lung metastases of cystic adenoidcarcinoma. A case report and review of the literature. Rev Pneumol Clin 2003;59(6):371-374
- Airoldi M, Fornari G, Pedani F, Marchionatti S, Gabriele P, Succo G: Paclitaxel and carboplatin for recurrent salivary gland malignancies. Anticancer Res 2000;20(5C):3781-3783
- Tedjarati S, Baker CH, Apte S, Huang S, Wolf JK, Killion JJ et al: Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel. Clin Cancer Res 2002;8:2413-2422
- Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW et al: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-2139 https://doi.org/10.1056/NEJMoa040938
- Chung SH, Park YW: An experimental study for establishment of orthotopic salivary tumor models in mice. J Kor Oral Maxillofac Surg 2007;33(2):81-93
- Friedman EW, Schwartz AE: Diagnosis of salivary gland tumors. Cancer 1974;24:266-273 https://doi.org/10.1002/1097-0142(196908)24:2<266::AID-CNCR2820240209>3.0.CO;2-#
- Craven RJ, Lightfoot H, Cance WG: A decade of tyrosine kinases: from gene discovery to therapeutics. Surg Oncol 2003;12:39-49 https://doi.org/10.1016/S0960-7404(03)00004-5
- Castilla MA, Neria F, Renedo G, Pereira DS, Gonzalez-Pacheco FR, Jimenez S et al: Tumor-induced endothelial cell activation: role of vascular endothelial growth factor. Am J Physiol Cell Physiol 2004;286(5):C1170-1176 https://doi.org/10.1152/ajpcell.00306.2003
- Chang C, Werb Z: The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends in Cell Biol 2001;11(11):S37-43 https://doi.org/10.1016/S0962-8924(01)82222-4
- Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K et al: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2:737-744 https://doi.org/10.1038/35036374
- Huang S, Van Arsdall M, Tedjarati S, McCarty M, Wu W, Langley R et al: Angiogenesis and progressive growth of human ovarian carcinoma is dependent on host metalloproteinase-9. J Natl Cancer (in press)
- Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM: Interleukin-8 as a macrophage derived mediator of angiogenesis. Science 1992;258:1798-1801 https://doi.org/10.1126/science.1281554
- Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L: The origin and function of tumor-associated macrophages. Immunol Today 1992;13:265-270 https://doi.org/10.1016/0167-5699(92)90008-U
- Sunderkkotter C, Steinbrink K, Goebeler M, Bhardwag R, Sorg C: Macrophages and angiogenesis. J Leukoc Biol 1994;55:410-422 https://doi.org/10.1002/jlb.55.3.410
- Donaldson KL, Goolsby GL, Wahl AF: Cytotoxicity of the anticancer agents cisplatin and Taxol during cell proliferation and the cell cycle. Int J Cancer 1994;57:847-855 https://doi.org/10.1002/ijc.2910570614
- Ciardiello F, Caputo R, Bianco R, Damiano V, Pomatico G, De Placido S et al: Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clin Cancer Res 2000;6(5):2053-2063
- Holsinger FC, Doan DD, Jasser SA, Swan EA, Greenberg JS, Schiff BA et al: Epidermal growth factor receptor blockade potentiates apoptosis mediated by Paclitaxel and leads to prolonged survival in a murine model of oral cancer. Clin Cancer Res 2003;9(8):3183-3189
- Sumitomo M, Asano T, Asakuma J, Asano T, Horiguchi A, Hayakawa M: ZD1839 modulates paclitaxel response in renal cancer by blocking paclitaxel-induced activation of the epidermal growth factor receptor-extracellular signal-regulated kinase pathway. Clin Cancer Res 2004;10(2):794-801 https://doi.org/10.1158/1078-0432.CCR-0948-03